Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume -, Issue -, Pages -
Publisher
American Society for Microbiology
Online
2022-06-01
DOI
10.1128/spectrum.00542-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins
- (2021) Florian Wagenlehner et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
- (2021) Po-Yu Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii
- (2020) V. Aranzana-Climent et al. CLINICAL MICROBIOLOGY AND INFECTION
- Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy
- (2020) Samuel L Aitken et al. CLINICAL INFECTIOUS DISEASES
- Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram‐negative Bloodstream Infections: “Every day matters”
- (2020) Thomas Lodise et al. PHARMACOTHERAPY
- A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
- (2020) Brian Luna et al. Nature Microbiology
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2020) Jiating Liu et al. Journal of Global Antimicrobial Resistance
- Minocycline alone and in combination with polymyxin B, meropenem, and sulbactam against carbapenem- susceptible and resistant Acinetobacter baumannii in in vitro pharmacodynamic model
- (2020) Maya Beganovic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii
- (2020) A R Noel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in China (including Hong Kong) and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013-2016)
- (2019) Cecilia G. Carvalhaes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017
- (2019) Michael D. Huband et al. Journal of Global Antimicrobial Resistance
- Multidrug-resistant Acinetobacter baumannii infections: current evidence on treatment options and role of PK/PD in dose optimization
- (2019) Sazlyna Mohd Sazlly Lim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans
- (2019) Jürgen B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence
- (2019) Paraskevi Fragkou et al. Microorganisms
- In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: Results from the SENTRY Antimicrobial Surveillance Program (2014-2018)
- (2019) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
- (2019) Yoshinori Yamano CLINICAL INFECTIOUS DISEASES
- Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics
- (2019) Keith A. Rodvold et al. CLINICAL PHARMACOKINETICS
- In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia
- (2019) Nam Su Ku et al. Scientific Reports
- Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
- (2019) David A. Butler et al. Current Infectious Disease Reports
- Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects
- (2018) Christopher M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
- (2018) L. Papst et al. CLINICAL MICROBIOLOGY AND INFECTION
- Absence of TetB Identifies Minocycline-Susceptible Isolates of Acinetobacter baumannii
- (2018) Olga Lomovskaya et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical use of the polymyxins: the tale of the fox and the cat
- (2018) Eric Wenzler et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- 1387. Phase I Study to Evaluate the Safety and Pharmacokinetics (PK) of Single and Multiple Ascending Doses (SAD/MAD) of Intravenous (IV) Minocycline in Healthy Adult Subjects
- (2018) Oliver A Cornely et al. Open Forum Infectious Diseases
- Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceae in North-Eastern France and outcomes of infected patients
- (2017) Anaëlle Muggeo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements
- (2017) Joseph D. Lutgring et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
- (2017) Bin Cai et al. Open Forum Infectious Diseases
- Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii
- (2016) Gauri G. Rao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database
- (2016) Baofeng Jia et al. NUCLEIC ACIDS RESEARCH
- Optimizing the Initial Amikacin Dosage in Adults
- (2015) Bryan P. White et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
- (2015) Dana R. Bowers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis
- (2014) Gokcen Dinc et al. CHEMOTHERAPY
- Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
- (2014) J. Alexander Viehman et al. DRUGS
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii
- (2013) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
- (2013) Laurence Armand-Lefèvre et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
- (2013) Michael P. Draper et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii
- (2013) S. T. Housman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of acquired antimicrobial resistance genes
- (2012) E. Zankari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore
- (2009) Tze-Peng Lim et al. JOURNAL OF ANTIBIOTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search